4Q03
Second-site screening of K-Ras in the presence of covalently attached first-site ligands
Summary for 4Q03
| Entry DOI | 10.2210/pdb4q03/pdb |
| Related | 4PZY 4PZZ 4Q01 4Q02 4Q03 |
| Descriptor | GTPase KRas, GUANOSINE-5'-DIPHOSPHATE, MAGNESIUM ION, ... (5 entities in total) |
| Functional Keywords | small gtpase, signaling transduction, sos, raf, hydrolase |
| Biological source | Homo sapiens (human) |
| Cellular location | Cell membrane; Lipid-anchor; Cytoplasmic side: P01116 |
| Total number of polymer chains | 1 |
| Total formula weight | 20027.47 |
| Authors | Sun, Q.,Phan, J.,Friberg, A.,Camper, D.V.,Olejniczak, E.T.,Fesik, S.W. (deposition date: 2014-03-31, release date: 2014-09-10, Last modification date: 2024-02-28) |
| Primary citation | Sun, Q.,Phan, J.,Friberg, A.R.,Camper, D.V.,Olejniczak, E.T.,Fesik, S.W. A method for the second-site screening of K-Ras in the presence of a covalently attached first-site ligand. J.Biomol.Nmr, 60:11-14, 2014 Cited by PubMed Abstract: K-Ras is a well-validated cancer target but is considered to be "undruggable" due to the lack of suitable binding pockets. We previously discovered small molecules that bind weakly to K-Ras but wanted to improve their binding affinities by identifying ligands that bind near our initial hits that we could link together. Here we describe an approach for identifying second site ligands that uses a cysteine residue to covalently attach a compound for tight binding to the first site pocket followed by a fragment screen for binding to a second site. This approach could be very useful for targeting Ras and other challenging drug targets. PubMed: 25087006DOI: 10.1007/s10858-014-9849-8 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.201 Å) |
Structure validation
Download full validation report
